1. Home
  2. MATH vs NVNO Comparison

MATH vs NVNO Comparison

Compare MATH & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • NVNO
  • Stock Information
  • Founded
  • MATH 2015
  • NVNO 1987
  • Country
  • MATH Hong Kong
  • NVNO United States
  • Employees
  • MATH N/A
  • NVNO N/A
  • Industry
  • MATH Finance/Investors Services
  • NVNO Medical/Dental Instruments
  • Sector
  • MATH Finance
  • NVNO Health Care
  • Exchange
  • MATH Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • MATH 60.8M
  • NVNO 71.0M
  • IPO Year
  • MATH N/A
  • NVNO N/A
  • Fundamental
  • Price
  • MATH $3.60
  • NVNO $4.20
  • Analyst Decision
  • MATH
  • NVNO
  • Analyst Count
  • MATH 0
  • NVNO 0
  • Target Price
  • MATH N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • MATH 197.9K
  • NVNO 93.8K
  • Earning Date
  • MATH 08-26-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • MATH N/A
  • NVNO N/A
  • EPS Growth
  • MATH N/A
  • NVNO N/A
  • EPS
  • MATH 0.17
  • NVNO N/A
  • Revenue
  • MATH $31,399,049.00
  • NVNO N/A
  • Revenue This Year
  • MATH N/A
  • NVNO N/A
  • Revenue Next Year
  • MATH N/A
  • NVNO N/A
  • P/E Ratio
  • MATH $22.72
  • NVNO N/A
  • Revenue Growth
  • MATH 291.58
  • NVNO N/A
  • 52 Week Low
  • MATH $0.80
  • NVNO $2.03
  • 52 Week High
  • MATH $4.17
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • MATH 61.32
  • NVNO 59.82
  • Support Level
  • MATH $3.55
  • NVNO $3.89
  • Resistance Level
  • MATH $3.97
  • NVNO $4.40
  • Average True Range (ATR)
  • MATH 0.32
  • NVNO 0.24
  • MACD
  • MATH 0.03
  • NVNO -0.02
  • Stochastic Oscillator
  • MATH 83.49
  • NVNO 64.06

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: